CoChat

Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses

Bogenschutz, Michael P., Pommy, Jessica M. · 2012 · Drug Testing and Analysis
Cited by 125

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

Alcohol and drug addiction are major public health problems, and existing treatments are only moderately effective. Although there has been interest for over half a century in the therapeutic use of classic hallucinogens to treat addictions, clinical research with these drugs was halted at an early stage in the early 1970s, leaving many fundamental questions unanswered. In the past two decades, clinical research on classic hallucinogens has resumed, although addiction treatment trials are only now beginning. The purpose of this paper is to provide a targeted review of the research most relevant to the therapeutic potential of hallucinogens, and to integrate this information with current thinking about addiction and recovery. On the basis of this information, we present a heuristic model which organizes a number of hypotheses that may be tested in future research. We conclude that existing evidence provides a convincing rationale for further research on the effects of classic hallucinogens in the treatment of addiction. Copyright © 2012 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/dta.1376

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Research works printed but not linked: 142

  1. Grinspoon L., 1997, Psychedelic Drugs Reconsidered
  2. Grof S., 2008, LSD Psychotherapy
  3. Leuner H., 1967, The Use of LSD in Psychotherapy and Alcoholism, 101
  4. Buckman J., 1967, The Use of LSD in Psychotherapy and Alcoholism, 83
  5. Hoffer A., 1967, The Use of LSD in Psychotherapy and Alcoholism, 343
  6. Sherwood J. N., 1962, The psychedelic experience–a new concept in psychotherapy, J. Neuropsychiatr., 4, 69
  7. Unger S. M., 1963, Mescaline, Lsd, Psilocybin, and Personality‐Change ‐ a Review, Psychiatry, 26, 111, 10.1080/00332747.1963.11023344 · DOI · Paper page
  8. 10.1001/archpsyc.1967.01730290009002 · DOI · Paper page
  9. 10.1037/h0088594 · DOI
  10. Savage C., 1966, The effects of psychedelic (LSD) therapy on values, personality, and behavior, Int. J. Neuropsychiatry, 2, 241
  11. 10.1080/00221309.1969.9710481 · DOI
  12. Abuzzahab F. S., 1971, A review of LSD treatment in alcoholism, Int. Pharmacopsychiat., 6, 223, 10.1159/000468273 · DOI · Paper page
  13. 10.3109/16066359609010756 · DOI · Paper page
  14. 10.1080/02791072.1998.10399714 · DOI · Paper page
  15. 10.1093/shm/hkl039 · DOI · Paper page
  16. Grof S., 1973, DPT as an adjunct in psychotherapy of alcoholics, Int. Pharmacopsychiat., 8, 104, 10.1159/000467979 · DOI · Paper page
  17. 10.1080/02791072.1977.10472060 · DOI
  18. Smart R. G., 1966, A controlled study of lysergide in the treatment of alcoholism. 1. The effects on drinking behavior, Q. J. Stud. Alcohol, 27, 469, 10.15288/qjsa.1966.27.469 · DOI · Paper page
  19. 10.1176/ajp.126.1.59 · DOI · Paper page
  20. 10.1097/00005053-197002000-00003 · DOI · Paper page
  21. Tomsovic M., 1970, Lysergide treatment of schizophrenic and nonschizophrenic alcoholics: a controlled evaluation, Q. J. Stud. Alcohol, 31, 932, 10.15288/qjsa.1970.31.932 · DOI · Paper page
  22. M. W.Johnson R. R.Griffiths.Psilocybin in smoking cessation: A pilot study in118th Annual Meeting of the American Psychological Association San Diego CA 2010. · doi:10.1037/e609562010-001
  23. 10.1371/journal.pone.0009019 · DOI · Paper page
  24. 10.1016/j.bcp.2007.07.018 · DOI · Paper page
  25. Glennon R. A., 2009, Principles of Addiction Medicine, 215
  26. 10.1093/cercor/13.8.870 · DOI · Paper page
  27. 10.1016/j.pnpbp.2007.07.009 · DOI
  28. 10.1523/JNEUROSCI.1665-10.2010 · DOI · Paper page
  29. 10.1073/pnas.0708862105 · DOI · Paper page
  30. 10.1016/j.neulet.2011.01.046 · DOI · Paper page
  31. 10.1111/j.1471-4159.2008.05357.x · DOI · Paper page
  32. Vaidya V. A., 1997, 5‐HT2A receptor‐mediated regulation of brain‐derived neurotrophic factor mRNA in the hippocampus and the neocortex, J. Neurosci., 17, 2785, 10.1523/JNEUROSCI.17-08-02785.1997 · DOI · Paper page
  33. 10.1016/j.neubiorev.2009.11.009 · DOI · Paper page
  34. Buckholtz N. S., 1990, Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain, Neuropsychopharmacol., 3, 137
  35. 10.1097/00005053-196312000-00007 · DOI · Paper page
  36. Pahnke W. N., 1971, The experimental use of psychedelic (LSD) psychotherapy, Int. Z. Klin. Pharmakol. Ther. Toxikol., 4, 446
  37. Stace W. T., 1960, Mysticism and Philosophy
  38. Pahnke W. N., 1969, Psychedelic drugs and mystical experience, Int. Psychiatry Clin., 5, 149
  39. 10.2307/1384454 · DOI · Paper page
  40. 10.1371/journal.pone.0014074 · DOI
  41. Roberts T. B., 1995, Religion and Psychoactive Sacraments: A Bibliographic Guide
  42. Kunitz S. J., 1994, Drinking Careers: A Twenty‐Five Year Study of Three Navajo Populations
  43. Halpern J. H., 2008, Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament, Med. Sci. Monit., 14, SR15
  44. 10.1080/02791072.2009.10399905 · DOI · Paper page
  45. 10.1177/009164718301100406 · DOI · Paper page
  46. Pahnke W., 1963, Drugs and Mysticism: An Analysis of the Relationship between Psychedelic Drugs and the Mystical Consciousness
  47. 10.1016/j.jep.2005.04.022 · DOI · Paper page
  48. Stewart O., 1987, The Peyote Religion: A History
  49. Meyerhoff B., 1974, Peyote Hunt
  50. Lu L., 2009, Traditional Medicine in the Treatment of Drug Addiction, Am. J. Drug Alcohol Ab., 35, 11
  51. 10.1525/maq.2000.14.4.521 · DOI
  52. 10.1016/j.biopsych.2005.06.038 · DOI · Paper page
  53. 10.1002/jclp.20000 · DOI · Paper page
  54. Emrick C. D., 2004, American Psychiatric Publishing Textbook of Substance Abuse Treatment, 433
  55. 1981, Twelve Steps and Twelve Traditions
  56. Wilson B., 2000, My First Forty Years
  57. 10.1002/jclp.20004 · DOI · Paper page
  58. 10.1300/J020v21n04_02 · DOI
  59. 10.1300/J020v21n01_01 · DOI · Paper page
  60. 10.1111/j.1530-0277.2007.00499.x · DOI · Paper page
  61. 10.1037/0893-164X.10.2.90 · DOI · Paper page
  62. 10.1111/j.1530-0277.2010.01362.x · DOI · Paper page
  63. 10.1177/0269881108094300 · DOI · Paper page
  64. 10.1017/S1461145709000169 · DOI · Paper page
  65. Krystal J. H., 2007, Ketamine and the potential role for rapid‐acting antidepressant medications, Swiss Med. Wkly., 137, 215, 10.4414/smw.2007.11932 · DOI · Paper page
  66. 10.1007/s11920-007-0063-1 · DOI · Paper page
  67. 10.1016/j.biopsych.2008.09.029 · DOI · Paper page
  68. 10.1016/j.pbb.2007.10.003 · DOI
  69. 10.1111/j.1360-0443.2006.01423.x · DOI · Paper page
  70. 10.1080/02791072.1998.10399709 · DOI · Paper page
  71. Grant B. F., 2004, Prevalence and co‐occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions, Arch. Gen. Psychiat., 61, 10
  72. 10.1007/s00127-003-0597-4 · DOI · Paper page
  73. 10.1016/j.comppsych.2008.09.003 · DOI
  74. 10.1038/mp.2008.41 · DOI · Paper page
  75. 10.1016/S0740-5472(03)00118-1 · DOI
  76. 10.15288/jsad.2010.71.434 · DOI
  77. 10.1016/j.biopsych.2004.05.009 · DOI
  78. 10.1016/j.drugalcdep.2004.09.004 · DOI · Paper page
  79. 10.1001/jama.291.15.1887 · DOI · Paper page
  80. 10.1111/j.1530-0277.1996.tb05263.x · DOI
  81. LeMarquand D., 1994, Serotonin and alcohol intake, abuse, and dependence: findings of animal studies, Biol. Psychiatry, 36, 27
  82. 10.2190/DE.37.3.d · DOI · Paper page
  83. 10.1016/S0306-4603(98)00005-7 · DOI
  84. Dubey C., 2010, Five Factor correlates: A comparison of substance abusers and non‐substance abusers, J. Ind. Acad. Appl. Psychology, 36, 107
  85. 10.1186/1471-244X-8-22 · DOI · Paper page
  86. 10.1037/0022-3514.84.2.411 · doi:10.1037/0022-3514.84.2.411 · Paper page
  87. 10.1016/j.addbeh.2010.06.008 · DOI · Paper page
  88. 10.1006/jrpe.2001.2326 · DOI
  89. 10.1016/j.psychres.2004.07.013 · DOI
  90. 10.1300/J069v25n04_06 · DOI
  91. 10.1186/1471-244X-3-1 · DOI · Paper page
  92. 10.1093/alcalc/34.2.254 · DOI · Paper page
  93. 10.1016/j.pharmthera.2010.09.007 · DOI · Paper page
  94. 10.15288/jsad.2007.68.641 · DOI · Paper page
  95. 10.1016/j.drugalcdep.2009.03.009 · DOI · Paper page
  96. 10.1111/j.1465-3362.2011.00303.x · DOI · Paper page
  97. 10.1037/a0025204 · DOI
  98. Heinz A., 2008, Identifying the neural circuitry of alcohol craving and relapse vulnerability, Addit. Biol., 14, 12
  99. 10.1016/B978-0-12-385506-0.00010-7 · DOI
  100. 10.1192/bjp.bp.107.041228 · DOI
  101. 10.1111/j.1530-0277.2007.00390.x · DOI · Paper page
  102. 10.1016/S0278-5846(03)00081-2 · DOI · Paper page
  103. 10.1192/bjp.bp.110.084178 · DOI · Paper page
  104. 10.1016/j.bcp.2007.08.005 · DOI · Paper page
  105. Swift R. M., 1999, Medications and Alcohol Craving, Alcohol Res. Health, 23, 7
  106. 10.1016/j.neubiorev.2011.03.005 · DOI
  107. 10.1093/alcalc/34.2.244 · DOI · Paper page
  108. 10.1046/j.1360-0443.1995.9018712.x · DOI
  109. 10.1176/ajp.152.3.391 · DOI · Paper page
  110. 10.1111/j.1530-0277.1996.tb01686.x · DOI · Paper page
  111. 10.1111/j.1530-0277.2000.tb04648.x · doi:10.1111/j.1530-0277.2000.tb04648.x · Paper page
  112. 10.1001/archpsyc.1997.01830200024004 · DOI · Paper page
  113. 10.1097/00004850-199409000-00004 · DOI · Paper page
  114. 10.1038/clpt.1992.85 · DOI
  115. 10.1007/978-1-4899-1678-5_13 · DOI
  116. Naranjo C. A., 1991, Possible pharmacological probes for predicting and preventing relapse in treated alcoholics, Alcohol Alcohol. Suppl., 1, 523
  117. 10.1001/jama.284.8.963 · DOI · Paper page
  118. 10.1176/appi.ajp.2010.10050755 · DOI · Paper page
  119. 10.1007/s00213-002-1002-9 · DOI
  120. 10.1037/0033-295X.84.2.191 · DOI · Paper page
  121. Bandura A., 1994, Encyclopedia of Human Behavior, 14
  122. Bandura A., 2001, Self‐Efficacy: The Exercise of Control
  123. 10.1016/j.addbeh.2011.07.032 · DOI · Paper page
  124. 10.1080/00952990701653818 · DOI
  125. 10.15288/jsa.2006.67.562 · DOI
  126. DiClemente C. C., 1999, Motivation for Change and Alcoholism Treatment, Alcohol Res. Health, 23, 7
  127. 10.1111/1467-9280.00137 · DOI · Paper page
  128. 10.1037/a0017189 · DOI · Paper page
  129. Miller W. R., 2006, A consensus statement on defining change talk, MINT Bulletin, 13, 6
  130. 10.1111/j.1749-6632.1998.tb08242.x · DOI · Paper page
  131. 10.1177/0960327107087802 · DOI · Paper page
  132. 10.1111/j.1749-6632.2000.tb06677.x · DOI
  133. 10.1523/JNEUROSCI.17-22-08828.1997 · DOI · Paper page
  134. Frecska E., 2006, The adverse effects of hallucinogens from intramural perspective, Neuropsychopharmacol. Hung., 8, 189
  135. 10.1523/JNEUROSCI.3959-04.2005 · DOI · Paper page
  136. 10.1111/j.1369-1600.2010.00251.x · DOI · Paper page
  137. 10.1038/tp.2011.57 · DOI
  138. 10.1073/pnas.0711755105 · DOI · Paper page
  139. 10.1016/j.pharmthera.2008.12.001 · DOI · Paper page
  140. 10.1300/J020V09N01_09 · DOI · Paper page
  141. 10.1080/02791072.2007.10399860 · DOI · Paper page
  142. 10.1207/s15473333thp3404_7 · DOI · Paper page

Cited by

Metadata

Authors
Bogenschutz, M. P., & Pommy, J. M.
Venue
Drug Testing and Analysis
Publisher
Wiley
Published
2012-07
Volume
4
Issue
7-8
Pages
543-555
ISSN
  • 1942-7603 (ISSN-L)
  • 1942-7611
OpenAlex
W1940682915
Cited by
125
References
42
FWCI
8.32
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.